Arbital Health Raises $31 Million in Series B

Arbital Health Raises $31 Million in Series B

Arbital Health, a San Francisco, CA-based healthcare technology company optimizing value-based care contracts, has raised $31 million in Series B funding.

The round was led by Valtruis, with participation from Transformation Capital, Shaper Capital, and Healthy Ventures.

Valtruis is a healthcare investment firm that partners with companies advancing value-based care. Backed by Welsh, Carson, Anderson & Stowe (WCAS), Valtruis provides capital, strategic expertise, and operational support to health-tech and healthcare services companies.

The company will use the funds to expand its AI-driven platform capabilities, grow its actuarial team, and enhance support for risk contract performance management, monitoring, and reconciliation across all major value-based care models.

Founded in 2024 by Travis May and Brian Overstreet, Arbital Health provides critical infrastructure for managing risk-based healthcare contracts. With value-based actuaries and a robust AI-powered platform, Arbital Health accelerates contract performance monitoring and decision-making, centralizes fragmented data, and automates contract reconciliation across all major risk models. Headquartered in San Francisco, California, Arbital supports over 40 healthcare entities and manages 600,000+ patient lives.

Funding Details

Company: Arbital Health, Inc.

Raised: $31.0M

Round: Series B

Funding Date: July 2025

Lead Investor: Valtruis

Additional Investors: Transformation Capital, Shaper Capital, Healthy Ventures

Company Website: https://www.arbitalhealth.com/

Software Category: Healthcare Tech / Value-Based Care / Risk Contract Management